NASDAQ: BTMD
Biote Corp Stock Ownership - Who owns Biote?

Insider buying vs selling

Have Biote Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BTMD insiders and whales buy or sell their stock.

BTMD Shareholders

What type of owners hold Biote Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gary Steven Donovitz59.86%22,494,946$50.84MInsider
Guines LLC23.38%8,787,048$19.86MInsider
325 Capital LLC12.10%4,548,127$10.28MInstitution
325 Capital LLC10.02%3,766,666$8.51MInsider
Andrew R. Heyer8.22%3,089,049$6.98MInsider
Roystone Capital Management LP8.17%3,070,938$6.94MInsider
Bandera Partners LLC5.50%2,065,482$4.67MInstitution
Blackrock Inc4.63%1,739,244$3.93MInstitution
Vanguard Capital Management LLC2.96%1,113,855$2.52MInstitution
Steven J. Heyer1.94%729,856$1.65MInsider

1 of 3

BTMD vs Medical Care Facility Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BTMD26.22%73.78%
PARK18.85%15.27%Net Buying
PIII0.09%99.91%
NAKA46.16%53.84%Net BuyingNet Buying
SRXH0.26%1.80%Net Buying

Biote Stock Ownership FAQ

Who owns Biote?

Biote (NASDAQ: BTMD) is owned by 40.41% institutional shareholders, 113.68% Biote insiders, and 0.00% retail investors. Gary Steven Donovitz is the largest individual Biote shareholder, owning 22.49M shares representing 59.86% of the company. Gary Steven Donovitz's Biote shares are currently valued at $50.61M.

If you're new to stock investing, here's how to buy Biote stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.